About Gabrielle

Gabrielle Rich Aouad grew up in Switzerland where she graduated from Aiglon School. She graduated with honors from Oxford University in England, earning her B.A. in philosophy and modern languages. Fluent in five languages, Gabrielle was a champion skier, an expert in horseback riding and a skilled rock mountain climber.

In the summer of 1991, she moved to New York and joined the NYU intensive film program where she met her future husband, Philip Aouad. At the tender age of 23, she was diagnosed with advanced stage Hodgkin’s disease. Her strength and feistiness never failed through months of painful treatment.

Our Inspiration

Over two decades of funding

Helping to improve the efficacy of cancer treatments, reduce their toxicity and improve the quality of life of patients.

The Foundation funds innovative clinical or basic science research that will lead to novel therapeutic approaches that could replace, or be used in combination with existing effective therapies for patients with leukemia and lymphoma. Such therapeutic approaches could include alternative or complementary medicine.

More about what we do

Who We Fund

Gabrielle's Angel Foundation has awarded more than $43 million in research grants to the best and brightest scientists in America.

Our most recent grantees include: Dr. Kevin Liou, Memorial Sloan Kettering Cancer Center; Dr. Tatiana Marquez-Lago, University of Alabama Birmingham; Dr. Riu Lu, University of Alabama Birmingham; Dr. Santosha Vardhana, Memorial Sloan Kettering Cancer Center; Dr. Sydney Lu, Stanford Medical School and Dr. Lai Chan , Cleveland Clinic/ Lerner Research Institute
Lai Chan, PhD
Lai Chan, PhD

Cleveland Clinic/ Lerner Research Institute, 2024

Kevin Liou, MD
Kevin Liou, MD

Memorial Sloan Kettering Cancer Center ~ Integrative Project, 2024

Riu Lu, PhD
Riu Lu, PhD

University of Alabama Birmingham, 2024

Sydney Lu, MD, PhD
Sydney Lu, MD, PhD

Stanford Medical School, 2024

Tatiana Marquez-Lago, PhD
Tatiana Marquez-Lago, PhD

University of Alabama Birmingham ~ Integrative, 2024

Santosha Vardhana, MD, PhD
Santosha Vardhana, MD, PhD

Memorial Sloan Kettering Cancer Center, 2024

Medical Advisory Board

Eduardo D. Bruera, MD
Eduardo D. Bruera, MD

The University of Texas, MD Anderson Cancer Center

Michael A. Caligiuri, MD
Michael A. Caligiuri, MD

City of Hope National Medical Center

Curt I. Civin, MD
Curt I. Civin, MD

University of Maryland School of Medicine

John F. DiPersio, MD, PhD
John F. DiPersio, MD, PhD

Washington University School of Medicine

Jerome E. Groopman, MD
Jerome E. Groopman, MD

Harvard Institute of Medicine

Carl H. June, MD
Carl H. June, MD

University of Pennsylvania School of Medicine

Stephen D. Nimer, MD – Chairman
Stephen D. Nimer, MD – Chairman

Sylvester Comprehensive Cancer Center

Eirini Papapetrou, MD, PhD
Eirini Papapetrou, MD, PhD

Icahn School of Medicine at Mount Sinai

Rainer Storb, MD
Rainer Storb, MD

Fred Hutchinson Cancer Research Center

Sarah Tasian, MD
Sarah Tasian, MD

Children’s Hospital of Philadelphia (CHOP)

Jeffrey D. White, MD
Jeffrey D. White, MD

Bethesda, Maryland

*Janet D. Rowley, M.D., D.Sc.
*Barrie R. Cassileth, Ph.D.

Events & News

EVENT

YPC GALA 2024

Gabrielle’s Angel Foundation’s Young Professionals Committee (YPC) raised $250,000 at their Midsummer Angel Glaa on June 4th at The Bowery Hotel!

EVENT

Angel Ball 2023

Gabrielle’s Angel Foundation for Cancer Research raised more than $3 million at Angel Ball on October 23rd at Cipriani Wall Street, hosted by co-founders, songwriter Denise Rich and her daughters Daniella Rich Kilstock and Ilona Rich Schachter. Click through for the full event recap!

NEWS

Gabrielle’s Angel Foundation welcomes new Medical Advisory Board member Dr. Sarah Tasian

We are delighted to welcome former Gabrielle's Angel Foundation grantee Dr. Sarah Tasian to the Medical Advisory Board of Gabrielle’s Angel Foundation for Cancer Research!

Fiscal responsibility

By the Numbers

We take the commitment of our donors seriously. By showing fiscal responsibility in program, administrative and fundraising costs, 88 cents of every dollar we raise directly funds the future leaders of cancer research.